[The clinical significance of serum anti-p53 antibody as a monitoring marker in colorectal cancer].

MLA

Amano, Kunihiko, et al. “[The Clinical Significance of Serum Anti-P53 Antibody as a Monitoring Marker in Colorectal Cancer].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 39, no. 12, Nov. 2012, pp. 2170–72. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23268013&authtype=sso&custid=ns315887.

APA

Amano, K., Kumamoto, K., Kuwabara, K., Ishiguro, T., Ohsawa, T., Okada, N., Kumagai, Y., Baba, H., Ishibashi, K., Tsuji, Y., Haga, N., & Ishida, H. (2012). [The clinical significance of serum anti-p53 antibody as a monitoring marker in colorectal cancer]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 39(12), 2170–2172.

Chicago

Amano, Kunihiko, Kensuke Kumamoto, Kouki Kuwabara, Toru Ishiguro, Tomonori Ohsawa, Norimichi Okada, Yoichi Kumagai, et al. 2012. “[The Clinical Significance of Serum Anti-P53 Antibody as a Monitoring Marker in Colorectal Cancer].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 39 (12): 2170–72. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=23268013&authtype=sso&custid=ns315887.